Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Travis Steed from Bank of America Securities maintained a Buy ...
In a report released on November 15, David Rescott from Robert W. Baird maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $100.00. Don't Miss our Black ...
Boston Scientific said Monday it has agreed to acquire Intera Oncology, which makes treatments for liver tumors primarily caused by metastatic colorectal cancer. Newton, Massachusetts-based Intera ...
In case you haven't heard, butt-lifting leggings are this year's official uniform. Our editors and experts handpick every product we feature. We may earn a commission from your purchases.
Boston Scientific continued its active M&A year with an agreement to buy privately held Cortex for an undisclosed amount. Cortex develops diagnostic mapping technology to detect potential signs and ...
Stacker believes in making the world’s data more accessible through storytelling. To that end, most Stacker stories are freely available to republish under a Creative Commons License, and we encourage ...
"I am looking for green been casserole," said the Boston resident ... % of Thanksgiving shoppers waited until the last minute to buy food, and 25% of them said it's because they are too busy.
As Boston Scientific’s pulsed field ablation ... The company has signed a deal to buy Cortex, which made its debut in late 2023, and its mapping system for identifying the electrical misfires ...
To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific said Monday it has agreed to acquire Intera Oncology, which makes treatments for liver ...